AURORA: inital results presented
07.05.2019
The initial results of AURORA were announced at the ESMO Breast Cancer Congress in Berlin, Germany, by Dr Philippe Aftimos, Co-Principal Investigator of the programme and Clinical Trials Development Leader at the Jules Bordet Institute in Brussels, Belgium.
He presented the results for the first 381 patients included out of a planned total of 1,000. The researchers have identified molecular alterations present in excess in metastases that may be correlated with the spread of cancer and increased resistance to standard treatments.
Read the full press release by BIG.
News
-
28.09.2023 Translational Work from GeparSepto published
The prognostic and predictive potential of CAV1/2 expression was analysed in the GeparSepto trial (GBG 069).
Mehr ... -
27.09.2023 GBG research at SABCS
GBG will present several posters at the San Antonio Breast Cancer Symposium 2023
Mehr ... -
21.09.2023 New review on Immune Cell Infiltration published
A review from the International Immuno-Oncology Biomarker Working about tumor immunology was published in the journal of pathology.
Mehr ... -
07.09.2023 Save the date! GBG Annual Scientific Meeting 2024
Das 21. Annual Scientific Meeting 2024 wird am 29.2. bis 1.3. in Frankfurt stattfinden.
Mehr ...